Medchart provides a B2B platform that connects businesses to patient‑authorized electronic health records, emphasizing informed consent and data portability. The company uses AI and machine learning to parse records and surface actionable "information" rather than raw, inconsistently formatted data. That capability is aimed at customers beyond direct care, including lawyers, insurance providers and clinical researchers, and use cases such as life‑insurance underwriting and real‑world evidence for pharma. Medchart began as a DTC product but pivoted to focus on business workflows after founder experiences highlighted scalability needs. The team is led by co‑founders James Bateman (CEO) and Derrick Chow and says it is positioned to capture growth enabled by the 21st Century Cures Act. Financially, Medchart announced a $17M raise across Series A and seed rounds to support its platform expansion.

Total raised

$17M

Funding rounds

2

Latest round

Series A

Latest activity

Apr 2021